ESR1 and breast cancer: Accordingly, Sox2 positivity is rare in luminal-A (ER+, PR+, low Ki-67) breast cancers (16), and more common in triple-negative (ER–, PR–, HER2–) breast cancers (9, 12, 14, 15).